Cannara Biotech Inc. reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported sales was CAD 0.909396 million compared to CAD 0.867912 million a year ago. Revenue was CAD 19.48 million compared to CAD 10.31 million a year ago.

Net income was CAD 2.11 million compared to CAD 0.002951 million a year ago. Basic earnings per share from continuing operations was CAD 0.02. Diluted earnings per share from continuing operations was CAD 0.02.